![Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant - ScienceDirect Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379122002154-fx1.jpg)
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant - ScienceDirect
![A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern | mBio A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern | mBio](https://journals.asm.org/cms/10.1128/mbio.01423-22/asset/d0ebc3f6-5a9d-478a-89ab-17be19c2b1fd/assets/images/medium/mbio.01423-22-f002.gif)
A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern | mBio
![Lab study shows omicron-blocking antibodies persist four months after a Pfizer-BioNTech booster - The Washington Post Lab study shows omicron-blocking antibodies persist four months after a Pfizer-BioNTech booster - The Washington Post](https://arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/UVMJHWDVQII6ZITNDQQ4C2Y4SM.jpg)
Lab study shows omicron-blocking antibodies persist four months after a Pfizer-BioNTech booster - The Washington Post
![The comparability of Anti-Spike SARS-CoV-2 antibody tests is time-dependent: a prospective observational study | medRxiv The comparability of Anti-Spike SARS-CoV-2 antibody tests is time-dependent: a prospective observational study | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2021/09/05/2021.08.26.21262426/F1.large.jpg)
The comparability of Anti-Spike SARS-CoV-2 antibody tests is time-dependent: a prospective observational study | medRxiv
![Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study - The Lancet Microbe Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study - The Lancet Microbe](https://www.thelancet.com/cms/asset/18f48ea1-5898-49ea-9426-efaeeacd7d30/gr1.jpg)
Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study - The Lancet Microbe
![Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination | Nature Medicine Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination | Nature Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-022-01705-6/MediaObjects/41591_2022_1705_Fig1_HTML.png)
Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination | Nature Medicine
![Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study - eClinicalMedicine Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study - eClinicalMedicine](https://www.thelancet.com/cms/asset/2eca5c26-b3eb-48e8-bd6e-8d7222fefd9b/gr1.jpg)
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study - eClinicalMedicine
![Booster critical as COVID-19 vaccine-induced antibodies wane in 6 months, don't protect against omicron Booster critical as COVID-19 vaccine-induced antibodies wane in 6 months, don't protect against omicron](https://content.presspage.com/uploads/2170/1920_51484223894-e94e0682d5-k.jpg?10000)
Booster critical as COVID-19 vaccine-induced antibodies wane in 6 months, don't protect against omicron
![Vaccines | Free Full-Text | The Influence of Booster Shot and SARS-CoV-2 Infection on the Anti-Spike Antibody Concentration One Year after the First COVID-19 Vaccine Dose Administration Vaccines | Free Full-Text | The Influence of Booster Shot and SARS-CoV-2 Infection on the Anti-Spike Antibody Concentration One Year after the First COVID-19 Vaccine Dose Administration](https://pub.mdpi-res.com/vaccines/vaccines-11-00278/article_deploy/html/images/vaccines-11-00278-g001.png?1676516145)
Vaccines | Free Full-Text | The Influence of Booster Shot and SARS-CoV-2 Infection on the Anti-Spike Antibody Concentration One Year after the First COVID-19 Vaccine Dose Administration
![Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What](https://www.mdpi.com/vaccines/vaccines-10-01924/article_deploy/html/images/vaccines-10-01924-g001.png)
Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
![SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster - The Lancet Infectious Diseases SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster - The Lancet Infectious Diseases](https://www.thelancet.com/cms/asset/f73b9dfc-2569-425e-ba38-99d908b3843b/gr1.jpg)
SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster - The Lancet Infectious Diseases
![Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response | Annals of the Rheumatic Diseases Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/80/10/1361/F1.large.jpg)
Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response | Annals of the Rheumatic Diseases
![Antibody Response to the BA.5 Bivalent Vaccine Shot: a Two-Year Follow-Up Study following Initial COVID-19 mRNA Vaccination | Microbiology Spectrum Antibody Response to the BA.5 Bivalent Vaccine Shot: a Two-Year Follow-Up Study following Initial COVID-19 mRNA Vaccination | Microbiology Spectrum](https://journals.asm.org/cms/10.1128/spectrum.01316-23/asset/8da18a23-ff75-4b19-a2e5-3a18a826938c/assets/images/large/spectrum.01316-23-f001.jpg)